Quick Answer: Monistat (miconazole) is an OTC vaginal antifungal sold as 1-, 3- and 7-day treatments, often with an external cream for itch. Diflucan (fluconazole) is a prescription oral pill; the CDC’s 2021 guidelines list a single 150 mg dose for uncomplicated infections. A 2020 Cochrane review of 26 trials found little or no difference in clinical cure between oral and vaginal antifungals. Vaginal products act locally and include soothing external cream; the pill is less messy but has more drug interactions and is avoided in pregnancy, where the CDC recommends topical azoles for 7 days. The Monistat label says not to self-treat if you have never had a yeast infection diagnosed by a doctor.
Monistat vs Diflucan at a Glance
| Feature | Monistat (miconazole) | Diflucan (fluconazole) |
|---|---|---|
| Availability | OTC | Prescription |
| Form | Vaginal insert, suppository or cream; external cream | Oral tablet |
| Typical regimen | 1, 3 or 7 days (product dependent) | Single 150 mg dose for uncomplicated infection (CDC) |
| Clinical cure (Cochrane 2020) | Similar to oral | Similar to vaginal |
| External itch relief | Included external cream in combination packs | No topical component |
| Key interactions | Warfarin (bleeding or bruising, per label) | Many: warfarin, some statins, certain heart-rhythm drugs and others |
| Pregnancy | CDC: 7-day topical azole is the recommended approach | Oral fluconazole generally avoided; linked to miscarriage risk in a large cohort |
| Condoms and diaphragms | Can be weakened by the product (label) | No effect on latex |
Doses above are from the current U.S. Drug Facts or prescribing labels listed in Sources. Always follow the label on the package you buy, because store brands and formulations differ.
Two Azole Antifungals, Two Routes
Vaginal yeast infections are most often caused by Candida albicans. Symptoms include itching, burning, redness and a thick, white discharge. Miconazole and fluconazole both belong to the azole class of antifungals, which block the production of ergosterol, an essential part of the fungal cell membrane. The difference is where they act: Monistat is applied inside the vagina (with an optional cream on the outer skin), while Diflucan is swallowed and reaches the vaginal tissue through the bloodstream.
Do They Work Equally Well?
Denison and colleagues (Cochrane Database of Systematic Reviews, 2020) analyzed 26 trials with 5,007 participants comparing oral and vaginal antifungals for uncomplicated infections. They found probably little or no difference in clinical cure at short-term follow-up (13 trials, 1,859 participants) and at long-term follow-up, with moderate-certainty evidence. As an illustration, the reviewers estimated that if 77% of people were clinically cured with vaginal treatment in the short term, the rate with oral treatment would be between 75% and 83%. The overall risk of bias of the included trials was high.
The CDC’s 2021 STI Treatment Guidelines list both approaches for uncomplicated vulvovaginal candidiasis: a range of OTC and prescription intravaginal azoles, including miconazole in several strengths, or oral fluconazole 150 mg as a single dose.
Which Works Faster?
Speed is one of the most-searched questions about these products. A vaginal product delivers drug directly to the irritated tissue, and combination packs include an external cream that targets itching on the vulva right away. Fluconazole takes time to be absorbed and distributed, although a single tablet keeps working for several days because of its long half-life. Either way, many people notice improvement within a few days, and full resolution can take up to a week. Note that a 1-day product does not mean symptoms disappear in one day; it means the medicine is given in a single dose.
Using Monistat
The Monistat 1 Combination Pack label, for example, contains a 1,200 mg miconazole nitrate vaginal insert plus 2% miconazole external cream. The insert is placed into the vagina with the applicator, and the external cream can be applied to itchy, irritated skin outside the vagina twice daily for up to 7 days. Lower-strength 3-day and 7-day versions spread treatment over more nights; some people find them gentler.
Important label warnings include:
- Do not use if you have never had a vaginal yeast infection diagnosed by a doctor.
- Ask a doctor first if you have lower abdominal, back or shoulder pain, fever, chills, nausea, vomiting or foul-smelling discharge; frequent infections (such as once a month, or three in six months); or have been exposed to HIV.
- Ask a doctor or pharmacist before use if you take warfarin, because bleeding or bruising may occur.
- Do not use tampons, douches, spermicides or other vaginal products during treatment, and avoid vaginal intercourse. The product can damage condoms and diaphragms so they may fail to prevent pregnancy or STIs.
Using Diflucan
The Diflucan prescribing information lists vaginal candidiasis among its uses. For uncomplicated infections, a single 150 mg tablet is typical. For severe or recurrent infections, clinicians may prescribe additional doses (for example, a dose every three days for a total of three doses) or a longer maintenance course; the CDC guidelines describe these regimens.
Fluconazole has notable drug interactions. The label describes interactions with warfarin (increased effect), certain oral diabetes medicines (sulfonylureas), phenytoin, some statins and other drugs, and contraindicates combination with several medicines that can prolong the QT interval, such as quinidine. Tell your prescriber and pharmacist about every medicine and supplement you take.
Pregnancy
The CDC guidelines recommend only topical azole therapy, applied for 7 days, for vulvovaginal candidiasis during pregnancy. In a nationwide Danish cohort (Mølgaard-Nielsen, JAMA, 2016), oral fluconazole use during pregnancy was associated with a higher risk of miscarriage compared with unexposed pregnancies (hazard ratio 1.48) and compared with topical azole use (hazard ratio 1.62). The Diflucan label also describes birth defects reported with high-dose, long-term maternal use. If you are pregnant or could be, see a clinician rather than self-treating.
When It Might Not Be Yeast
Many people who self-diagnose a yeast infection actually have something else, such as bacterial vaginosis, trichomoniasis or a skin condition. These need different treatment, and antifungals will not help. A fishy odor, gray or green discharge, sores, or pelvic pain suggest another cause. If symptoms do not improve after treatment, the Monistat label advises seeing a doctor.
Recurrent Infections
Having three or more symptomatic infections in a year is considered recurrent vulvovaginal candidiasis. The CDC recommends a clinical evaluation, including culture to identify the species, because non-albicans species such as Candida glabrata may respond poorly to standard azoles. Recurrent infections may be managed with an initial longer course and then weekly oral fluconazole for months under a clinician’s supervision. Diabetes, recent antibiotics and a weakened immune system can contribute and should be evaluated.
Choosing Between Them
- Previously diagnosed, typical symptoms: an OTC Monistat product is a reasonable self-care option; choose the 3- or 7-day version if 1-day products irritate you.
- Prefer no mess or a single pill: ask a clinician about fluconazole; telehealth visits commonly handle this.
- Pregnant: see a clinician; a 7-day topical azole is the CDC-recommended approach.
- Taking warfarin or many other drugs: speak to a pharmacist before using either.
Understanding 1-, 3- and 7-Day Products
The CDC guidelines list several OTC miconazole regimens for uncomplicated infections, including 2% cream for 7 days, 4% cream for 3 days, a 100 mg vaginal suppository for 7 days, a 200 mg suppository for 3 days, and a 1,200 mg suppository as a single application; clotrimazole and tioconazole products are also listed. All of these are considered options, and the right one depends mostly on preference. Shorter regimens deliver a higher strength in fewer nights, while 7-day regimens deliver a lower strength over a longer period, which some people find gentler on already irritated tissue. The CDC also notes that creams and suppositories in these regimens are oil-based and might weaken latex condoms and diaphragms.
When to Talk to Your Doctor or Pharmacist
See a clinician if this is your first yeast infection, if you are pregnant or under 12, if you have fever, chills, pelvic or abdominal pain, a foul-smelling discharge or sores, if symptoms do not improve after treatment, or if infections recur (three or more a year). Seek urgent care for signs of an allergic reaction such as hives or facial swelling.
Frequently Asked Questions
Does Diflucan work faster than Monistat?
Not clearly. A Cochrane review found similar clinical cure rates for oral and vaginal antifungals. Vaginal products with external cream act directly on irritated skin, while one fluconazole tablet keeps working for several days.
Can I use Monistat and Diflucan together?
Some clinicians combine an oral antifungal with an external cream for itch, but ask a clinician first; doubling treatment is not usually needed for uncomplicated infections.
Is Diflucan available over the counter?
No. In the US, fluconazole requires a prescription. Monistat and other vaginal azoles are OTC.
Can I take Diflucan while pregnant?
The CDC recommends a 7-day topical azole in pregnancy. Oral fluconazole was linked to a higher miscarriage risk in a large Danish cohort.
Is Monistat 1 or Monistat 7 better?
The CDC lists several durations as options. Shorter regimens use higher strengths; some people find 3- or 7-day versions less irritating.
Can Monistat cause burning?
Yes. Burning, itching or irritation are listed effects, especially early in treatment. Stop and ask a doctor if they are severe.
Sources
- DailyMed: Monistat 1 Combination Pack (miconazole nitrate) Drug Facts
- DailyMed: Diflucan (fluconazole) prescribing information
- PubMed: Denison et al., oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (Cochrane, 2020)
- PubMed: Workowski et al., Sexually Transmitted Infections Treatment Guidelines, 2021 (CDC, MMWR)
- CDC: Vulvovaginal candidiasis, STI Treatment Guidelines
- PubMed: Mølgaard-Nielsen et al., oral fluconazole during pregnancy and risk of spontaneous abortion and stillbirth (JAMA, 2016)
- MedlinePlus: Fluconazole
- MedlinePlus: Miconazole vaginal
Medical disclaimer: This article is for educational purposes and does not replace medical advice. Consult a licensed healthcare provider before starting any supplement, medication, or treatment — particularly if you are pregnant, breastfeeding, taking other medications, or have a diagnosed medical condition.